Trials / Completed
CompletedNCT04163757
The Effects of Crocin Supplementation on Metabolic Parameters, Oxidative Stress, AMP- Activated Protein Kinase and Inflammation-promoting Genes Expression in Peripheral Blood Mononuclear Cells in Patients With Type 2 Diabetes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- National Nutrition and Food Technology Institute · Academic / Other
- Sex
- All
- Age
- 40 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
To study the effects of crocin supplement in patients with type 2 diabetes, 50 patients will be randomly allocated to placebo group and 2 tablets of crocin for 12 weeks. At the first and the end of the intervention, lipid profiles, blood pressure, blood sugar, inflammatory and anthropometric factors will be assessed and compared between groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | crocin | 2 tablets crocin per day |
| DIETARY_SUPPLEMENT | placebo | 2 tablets placebo per day |
Timeline
- Start date
- 2019-01-20
- Primary completion
- 2019-03-06
- Completion
- 2019-06-03
- First posted
- 2019-11-15
- Last updated
- 2019-11-15
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT04163757. Inclusion in this directory is not an endorsement.